Company intelligence / Profile preview

Ecomedic

Duernten, Zurich, Switzerland

Ownership: Private
Development stage: Other

Overview

ECO MEDICS products, such as the ANALYZER CLD 88 sp and EXHALYZER D, are globally commercialized for clinical and research pulmonary diagnostics; FeNO, N₂-washout, and other sophisticated tests used in asthma, PCD, and small airway diseases; devices are MDR and CE MDD certified and manufactured under ISO 13485:2016 and ISO 9001:2015 standards.

Therapeutic areas: PulmonologyRare Diseases
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Distribution partnerships worldwide with hospitals, clinics, and research institutes

Beyond the preview

Go deeper on Ecomedic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ecomedic.

Explore the full profile